A recent study highlights a cheaper and more efficient method to produce the artificial sweetener tagatose. However, does ...

One way to think about NAD+ is as an energy courier. It shuttles electrons to the mitochondria, where ATP is produced. When ...

Before Canada decides to rely on foreign drug regulators to approve new medicines, Health Canada needs to show that it will ...

The Alzheimer’s drugs market is projected to grow at a compound annual growth rate (CAGR) of around 20% during the forecast ...

Curious whether kombucha is good for you? The fermented tea offers probiotics and antioxidants that may benefit gut health and overall well-being.

Even with breakthroughs, treatment for advanced squamous cell carcinoma is more complex. Patients often need more than one treatment. Many patients with this advanced cancer are cared for by a team of ...

The FDA needs to strengthen guardrails to ensure its accelerated approval pathway is used appropriately, the HHS Office of Inspector General (OIG) said. The agency should do two things, the OIG ...

Amyloid-targeted monoclonal antibodies are the first disease-modifying therapies (DMTs) approved for Alzhemier’s disease (AD). Aducanumab received accelerated approval by the FDA but was not fully ...

Novel therapies for Alzheimer’s disease, particularly anti-amyloid drugs like lecanemab and donanemab, have shown modest clinical benefits but also significant risks. The present paper highlights the ...

Potential disease-modifying targets of Alzheimer’s disease include (but not limited to) amyloid (A), tau (T), neurodegeneration (N), inflammation (I), vascular injury (V), and α-synuclein (S).